Advertisement

AIDS-defining illnesses

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most

July 25, 2000

NEW YORK, July 24 (Praxis Press) The introduction of highly active antiretroviral therapy (HAART) may have altered clinical patterns of HIV-related diseases. Mocroft and colleagues studied the incidence and types of AIDS-defining illnesses (ADIs) in European outpatient clinics between 1994 (pre-HAART) and 1998 (post-HAART). The incidence of ADIs declined significantly, and rates of ADIs were lower among patients receiving HAART for all CD4-cell strata. Non-Hodgkin lymphoma became one of the most common ADIs. Although HAART has decreased the incidence of ADIs, physicians are likely to encounter previously uncommon types of ADIs.

Advertisement

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences